HOXA5 regulates expression of the progesterone receptor

J Biol Chem. 2000 Aug 25;275(34):26551-5. doi: 10.1074/jbc.C000324200.

Abstract

The majority of breast carcinomas show reduced or no expression of the transcription factor, HOXA5. Recently, we have shown that HOXA5 is a potent transactivator of p53 in breast cells and thus may affect the response of breast cancer cells to DNA damage. To determine whether HOXA5 played a role in growth and homeostasis in breast cells, we studied its interaction with the progesterone receptor. The progesterone receptor (PR) belongs to the superfamily of nuclear receptors whose members co-ordinate morphogenesis of the mammary gland in response to binding to their cognate ligands. An increased expression of the endogenous PR gene was seen in MCF-7 cells following induced expression of an exogenously transfected HOXA5 gene. HOXA5, but not HOXB4, -B5, or -B7 activated the PR promoter in two breast cancer cell lines, MCF-7 and Hs578T. Deletion and mutation analysis of the promoter identified a single HOXA5-binding site required for transactivation of the PR gene by HOXA5. HOXA5 binds directly to this site in the PR promoter. Thus, HOXA5 may behave as a transcriptional regulator of multiple target genes, two among which are p53 and the progesterone receptor.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • Binding Sites
  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism
  • Female
  • Gene Expression Regulation, Neoplastic
  • Genes, Reporter
  • Homeodomain Proteins / physiology*
  • Humans
  • Luciferases / genetics
  • Molecular Sequence Data
  • Phosphoproteins / physiology*
  • Receptors, Progesterone / biosynthesis*
  • Receptors, Progesterone / genetics
  • Transcription Factors / physiology*
  • Tumor Cells, Cultured

Substances

  • HOXA5 protein, human
  • Homeodomain Proteins
  • Phosphoproteins
  • Receptors, Progesterone
  • Transcription Factors
  • Luciferases